7
How TransCelerate is digitalizing patient engagement in clinical trials
How TransCelerate is digitalizing patient engagement in clinical trials
Despite the potential to serve a variety of functions in clinical trials, patient-facing digital technologies are not yet accepted as mainstream research tools.
Alison Bond, Director of Global Regulatory Policy & Intelligence at Janssen tells us about a new Patient Technology Initiative to optimize clinical trials through utilizing this technology.
Read more.
Created with Sketch.